US Stock Market Move | Lower the price of small bottles of the weight loss drug Zepbound, Eli Lilly (LLY.US) rises more than 2% against the trend.

On Tuesday, Eli Lilly (LLY.US) defied the trend with a rise of over 2%, closing at $902.26. In terms of news, Eli Lilly is increasing its efforts to combat cheap Zepbound counterfeit products. The company announced on its official website that it will lower the price of the popular weight-loss drug Zepbound in "small bottle" form. According to a statement, the company will reduce the prices of the 2.5 mg and 5 mg Zepbound bottles to $349 and $499 per month, respectively. This is about $50 lower than the current prices.